title: Treatment of sarcoidosis.
abstract: The treatment of pulmonary sarcoidosis is based on several factors. These include changes in pulmonary physiology, presence of extra-pulmonary disease, and symptoms. Several immunosuppressive agents have been studied and recommendations regarding the utility of these different agents have evolved. While glucocorticoids remain the most commonly used agent, other drugs have been used as steroid sparing and for those patients who progress despite routine treatment. Non immunosuppressive agents also play a role in the therapy of pulmonary sarcoidosis patients. These include treatments for pulmonary hypertension, infection, and fatigue.
authors.affiliation: Department of Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA. bob.baughman@uc.edu
authors.forename: R P
authors.initials: RP
authors.lastname: Baughman
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012507:Sarcoidosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D017565:Sarcoidosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents